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Expression of the Nuclear Receptor Coactivator, cAMP
Response Element-Binding Protein, Is Sexually
Dimorphic and Modulates Sexual Differentiation of
Neonatal Rat Brain
A. P. AUGER, T. S. PERROT-SINAL, C. J. AUGER, L. A. EKAS, M. J. TETEL, AND M. M. MCCARTHY
Department of Physiology (A.P.A., T.S.P.-S., L.A.E., M.M.M.), University of Maryland, Baltimore, Maryland 21201;
Psychology Department (C.J.A.), Johns Hopkins University, Baltimore, Maryland 21218; and Department of Biology
(M.J.T.), Skidmore College, Saratoga Springs, New York 12866
Recent studies indicate that the transcriptional activity of
steroid receptors is governed by proteins called nuclear re-
ceptor coactivators. Using immunocytochemistry, we found
that on the day of birth (postnatal d 0) males express higher
levels of the nuclear receptor coactivator, cAMP response el-
ement binding protein-binding protein (CBP), within the ven-
tromedial hypothalamus, medial preoptic area, and arcuate
nucleus. Using Western immunoblots, we confirmed that
males have higher levels of CBP on postnatal d 0, 1, and 5;
however, there was no sex difference on postnatal d 11. To
examine the functional role of CBP, we infused oligode-
oxynucleotides that were antisense to CBP mRNA or a scram-
bled sequence as a control into the hypothalamus of female
rats on postnatal d 0, 1, and 2. On postnatal d 1, all rats were
injected with 100 g testosterone propionate to both mascu-
linize (increase male) and defeminize (decrease female) sex-
ual behavior. Rats were ovariectomized in adulthood and
tested for adult sexual behavior. Neonatal CBP antisense oli-
godeoxynucleotides treatment interfered with the defeminiz-
ing, but not the masculinizing, actions of testosterone. These
results indicate that CBP expression in developing rat brain
is sexually dimorphic and an important modulator for steroid
hormone action. (Endocrinology 143: 3009–3016, 2002)
STEROID HORMONES ACT in the brain to influence awide variety of behavioral and physiological processes,
largely by binding to intracellular steroid receptors (1, 2). It
is well established that steroid receptors exert most of their
effects in cells by binding to hormone response elements
(HREs) on DNA and influencing gene transcription (3). Re-
cent studies indicate that steroid receptors also interact with
other regulatory proteins, nuclear receptor coactivators or
corepressors, that increase or decrease, respectively, their
binding and action at the HRE (4, 5). The nuclear coactivator
found to enhance transcriptional activity of progestin recep-
tors when bound to its HRE was termed steroid receptor
coactivator-1 (SRC-1) because it also enhances the transcrip-
tional activity of receptors for estrogens, androgens, glu-
cocorticoids, and thyroid hormone (6). Since SRC-1 was first
characterized, other coactivators have been identified, such
as the SRC-1-related proteins, TIF2 (SRC-2) and SRC-3, and
unrelated coactivators such as ARA70, Trip1, and TIF1. The
cAMP response element-binding protein (CREB)-binding
protein (CBP), which was originally identified as a coacti-
vator for CREB (7, 8), appears to function as a nuclear re-
ceptor coactivator by interacting with SRC-1 (9) and syner-
gistically enhance steroid receptor action at the HRE (4, 10).
Nuclear receptor coactivators increase steroid receptor
transcription via their intrinsic histone acetyltransferase ac-
tivity. Acetylation of histones by coactivators removes a pos-
itive charge, leading to a reduction in higher-order chromatin
structures, and makes DNA more accessible to transcription
factors (11–13). Nuclear receptor coactivators also increase
transcriptional activity of steroid receptors by interacting
with other histone acetyltransferase factors, such as p300/
CBP-associated factor, and general transcription factors,
such as TBP and TIFIIB (5). Because the actions of steroid
receptors are important for normal reproductive physiology
and behavior of both males and females and the actions of
steroid receptors at the genome are governed by nuclear
receptor coactivators, it is important to determine the ex-
pression and function of these nuclear receptor coactivators
(i.e. CBP) during brain development.
Although much is known about CBP in vitro, little is
known about the functional role of CBP in developing brain.
Homozygous mice containing a targeted disruption of the
CBP gene die during midgestation (14). Although heterozy-
gous mice survive, they show postnatal disruptions in neu-
rotube development as well as deficits in learning and mem-
ory, indicating that CBP is required for normal central
nervous system development and function (15). In adult rat
brain, CBP is found in many areas that also contain steroid
receptors, such as the amygdala, hypothalamus, and hip-
pocampus (16). In addition, CBP appears to be regulated by
estradiol because treatment of cultured hippocampal neu-
rons with estradiol increases the level of CBP within 24 h (17).
The time course for estradiol-induced CBP correlates with
Abbreviations: Arc, Arcuate nucleus; CBP, CREB-binding protein;
CREB, cAMP response element-binding protein; GAPDH, glyceralde-
hyde-3-phosphate dehydrogenase; HRE, hormone response element;
MPOA, medial preoptic area; ODN, oligodeoxynucleotide; PN0, post-
natal d 0; PVP, paraventricular thalamic nucleus, posterior part; SRC-1,
steroid receptor coactivator-1; TBS, Tris-buffered saline; TTBS, TBS con-
taining 0.05% Tween-20; VMH, ventromedial hypothalamus.
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estradiol-induced increases in neuronal dendritic spines, the
sites of excitatory synapses, and one of the more pronounced
sex differences in the brain is the density of dendritic spines
(18, 19). Therefore, we hypothesized that CBP is involved in
processes related to sexual differentiation of the brain.
Sexual differentiation of the brain is determined by steroid
hormone exposure during a discrete developmental period,
between embryonic d 18 and postnatal d 10 (20–22). At birth,
male rats are exposed to high levels of testosterone released
from the testis, resulting in behavioral masculinization, de-
fined as increased male-typical behaviors, and behavioral
defeminization, defined as decreased female-typical behav-
iors. The absence of a testosterone surge in females results in
feminization of the brain. Neonatally castrated male rats
grown to adulthood exhibit decreased male and increased
female sexual behavior under the appropriate hormonal con-
ditions (23). Likewise, females administered testosterone
neonatally do not display female sexual behavior as adults
(24, 25) but will display male-typical behaviors if treated with
exogenous testosterone. We have recently reported that
SRC-1 is critical for steroid-mediated differentiation of sexual
behavior. Reducing SRC-1 expression during the first few
days of life nearly abolished testosterone’s effect on sup-
pressing female sexual behavior in males and androgenized
females (26). Interestingly, reducing SRC-1 expression did
not interfere with the development of male sexual behavior
in males and androgenized females, suggesting the effects
were specific to defeminization. Because CBP interacts with
SRC-1 in vitro, we have now investigated the expression of
CBP and its function in sexual differentiation of neonatal
male and female rat brain.
Materials and Methods
Animals
Adult female Sprague Dawley rats (Charles River Laboratories, Inc.,
Wilmington, MA) were mated in our animal facility and mating con-
firmed by the presence of sperm in vaginal smears. Pregnant females
were allowed to deliver normally. Cages were checked regularly to
determine the day of birth. Pups were collected on the afternoon of the
day of birth (postnatal d 0, PN0), 24 h later (postnatal d 1), postnatal d
5, or postnatal d 11.
Experiment 1: quantification of CBP using
immunocytochemistry
On PN0, brains were collected from newborn male (n 5) and female
(n 6) pups and immediately immersed in 5% acrolein for 24 h and then
placed into 0.1 m PBS containing 20% sucrose overnight. Brains were
sectioned at 50m using a cryostat at20 C and stored in cryoprotectant
until processed for CBP immunocytochemistry.
CBP immunocytochemistry
Sections were rinsed three times for 5 min each in 0.1 m PBS (pH 7.6)
and placed into 1% H2O2, 20% normal goat serum, and 1% BSA for 30
min to reduce nonspecific staining and endogenous peroxidase activity.
Sections were then incubated with an antibody that recognizes the
carboxy terminus of CBP (rabbit polyclonal, SC-20; 1:2000 dilution, Santa
Cruz Biotechnology, Inc., Santa Cruz, CA) overnight at room temper-
ature in PBS containing 0.3% Triton X-100. After primary incubation,
sections were rinsed three times in PBS for 5 min each and then incubated
with biotinylated goat antirabbit IgG (7.5 g/ml) diluted in PBS for 90 min
at room temperature. Following three additional rinses in PBS, sections
were incubated with the DH:biotinylated horseradish peroxidase H
complex (1:200 in PBS) for 90 min. Sections were rinsed three more times
in PBS for 5 min each and treated with 0.05% diaminobenzidine and
0.05% H2O2 in PBS for 5 min. Developed sections were mounted onto
gelatin-coated slides and coverslipped with Permount mounting me-
dium. Omission of CBP antibody and preadsorption with CBP control
peptide blocked all immunoreactivity.
Computer-aided image analysis
Brain areas examined are illustrated in Fig. 1 and include areas that
express high levels of gonadal steroid receptors, such as the medial
preoptic area (MPOA), arcuate nucleus (Arc), ventromedial hypothal-
amus (VMH), and the CA1 and CA3 regions of the hippocampus, and
areas that contain little or no gonadal steroid receptor expression, such
as the paraventricular thalamic nucleus, posterior part (PVP), and the
frontal cortex. One section per area was matched according to the rat
brain atlas of Paxinos and Watson (27).
CBP-immunoreactive cells were counted using a Ziess microscope
fitted with an MTI CCD72 camera (Dage-MTI, Michigan City, IN)
connected to a Macintosh computer. The software used for analysis was
the public domain NIH IMAGE program (http://rsb.info.nih.gov/
nih-image). The microscope was set to Kohler illumination at 10  10
magnification. Details of this procedure have been published previously
(28, 29). Data were analyzed with a two-tailed t test using the SigmaStat
Statistical Analysis System 1.01 software (Jandel Scientific, Corta
Madera, CA).
FIG. 1. Schematic drawing of areas in which CBP immunoreactive
cell number was quantified. Figures are adapted from Paxinos and
Watson (27). Boxes represent the area used for image analysis within
a given region. Regions examined are the MPOA, VMH, Arc, PVP, and
a region of the frontal cortex (Ctx).
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Experiment 2: quantification of CBP by Western
immunoblotting
Neonatal male and female rat brains (five to six rats per group) were
collected on PN0, postnatal d 1, postnatal d 5, and postnatal d 11. The
basomedial hypothalamus was dissected out on a chilled surface, snap
frozen in isopentane on dry ice, and stored frozen until homogenization
with ice-cold lysis buffer consisting of 50 mm Tris-HCl, 1% Na-deoxy-
cholate, 0.25% Nonidet P-40, 150 mm NaCl, 1 mm EDTA, and protease
inhibitors (1 g/ml aprotinin, leupeptin, and pepstatin; 1 mm phenyl-
methylsulfonyl fluoride). Following tissue homogenization, samples
were centrifuged at 2000 g for 30 min at 4 C to sediment cellular debris
and nuclei. The supernatant fraction was collected and protein concen-
tration determined by a Bradford assay. Twenty micrograms total pro-
tein from each rat were gel electrophoresed using a precast SDS-PAGE
(8–16% Tris Glycine) and transferred to a polyvinyl difluoride mem-
brane. Membranes were washed briefly in 0.1 m Tris-buffered saline
(TBS) and blocked for 1 h in 0.1 m TBS containing 5% nonfat dry milk
with constant agitation at room temperature. Membranes were then
incubated with CBP antibody (SC-20; 1:3000) in TBS containing 0.05%
Tween-20 (TTBS) for 3 h at room temperature with agitation and washed
three times for 5 min each in TTBS. Following washes, membranes were
incubated in a goat antirabbit horseradish peroxidase-linked secondary
antibody for 30 min at room temperature with agitation and then
washed three times for 5 min each in TTBS. Immunoreactive bands were
detected using an enhanced chemiluminescence kit (New England Bio-
labs, Inc., Beverly, MA) and membrane exposed to film (Hyperfilm-ECL,
Amersham, Arlington Heights, IL). Membranes were then reblotted
with a mouse monoclonal antibody against the housekeeping gene,
glyceraldehyde-3-phosphate dehydrogenase (GAPDH; 1:100,000,
Chemicon International, Inc., Temecula, CA). Films were placed on a
light box and analyzed using a gel-plotting macro in the public domain
NIH image program. Densitometric areas were then were analyzed with
a two-tailed t test.
Experiment 3: functional consequence of reducing CBP
protein using antisense oligodeoxynucleotides
Oligodeoxynucleotide infusions. CBP antisense oligodeoxynucleotides
(ODNs) (n  4) or scrambled control ODNs (n  6) were infused into
the hypothalamus of female rats on PN0–2, using a modified stereotaxic
apparatus and a 1-l Hamilton syringe. Rats were cryoanesthetized
before each infusion. Bregma is visible through the skin under bright
light and was used as a landmark for the hypothalamus. Bilateral in-
jections (1 g ODNs dissolved in 1 l 0.9% saline) were aimed at the
mediobasal hypothalamus (1.0 mm anterior and 0.8 mm lateral to Breg-
ma; 5.0 mm below the skull). The sequence for the 21-mer antisense
oligonucleotide spanning the putative start codon of CBP is 5-CAG-
CAA-GTT-CTC-GGC-CAT-CTT-3 and the 21-mer scrambled control
oligonucleotide is 5-CCC-TAG-CAG-CTA-CAG-CTT-CGC-3. Chi-
meric ODNs were obtained from Oligos etc. (Wilforshire, OR). These
second-generation chimeric ODNs contain limited phosphorothioate
linkages allowing for greater resistance to nuclease cleavage and in-
creased activation of Rnase H, an enzyme that cleaves the RNA strand
of DNA/RNA hybrids. On postnatal d 1, all females were injected with
100 g testosterone propionate, a dose known to both masculinize and
defeminize sexual behavior.
Female sexual behavior. Neonatally treated rats were grown to adulthood
and ovariectomized on postnatal d 45 using ketamine/acepromazine
anesthesia. Two weeks following surgery, rats were steroid primed with
10 g estradiol benzoate followed 48 h later by 500 g progesterone, a
paradigm that reliably induces female sexual behavior. Fours hours after
progesterone treatment, rats were placed in a testing chamber and al-
lowed to acclimate. Behavioral testing occurred during the dark phase
of the light cycle under dim red light. The flanks and perineum were
manually stimulated by the experimenter and lordosis quotients and
ratings scored. Lordosis quotients indicate number of responses per
number of attempts multiplied by 100. Lordosis rating indicates a lor-
dosis intensity range on a scale from 0 to 3, reflecting increasing dor-
soflexion of the back. The experimenter scoring the lordosis response
was blind to the treatment group.
Male sexual behavior. Following testing for female sexual behavior, rats
were implanted with testosterone-filled capsules and 3 wk later tested
for male sexual behavior. Rats were then placed in a testing chamber and
allowed to acclimate. A sexually receptive female was placed into the
testing chamber, and the total number of mounts and latency to first
mount were recorded over a 15-min test period. Behavioral testing
occurred during the dark phase of the light cycle under dim red light.
Behavioral data were analyzed with a two-tailed t test.
Results
Experiment 1: quantification of CBP by
immunocytochemistry
On PN0, CBP immunoreactivity was found to be widely
expressed throughout male and female rat brain. A sex dif-
ference was found in the number of CBP immunoreactive
cells within brain regions that have high levels of gonadal
steroid receptors. In the MPOA, males had 53% more CBP
immunoreactive cells than females (males 5625  sem 447,
females 3662  538; P  0.05). In the VMH, males had 83%
more CBP immunoreactive cells (males 3810  205, females
2085 565; P 0.05; Fig. 2). In the Arc, males had 89% more
CBP immunoreactive cells than females (males 567  33,
females 299  89; P  0.05). There were no sex differences
found in brain regions that have little to no expression of
gonadal steroid receptors, such as the PVP (males 355  42,
females 369 38; P 0.05) or the frontal cortex (males 724
33, females 744  61; P  0.05; Fig. 3).
FIG. 2. Photomicrographs of CBP immunoreactive cells within the
VMH and the adjacent Arc of female and male rat brain.
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Experiment 2: quantification of CBP by
Western immunoblotting
Confirming immunocytochemical results, males had
higher levels of CBP within the basomedial hypothalamus on
PN0 (P  0.05, Figs. 4 and 5A). Males also had higher CBP
levels within the basomedial hypothalamus on PN1 and on
PN5 (P 0.05, Fig. 5, B and C). However, this difference was
not present on postnatal d 11 (P 0.05, Fig. 5D), a time point
outside the sensitive period for sexual differentiation.
Experiment 3: functional consequence of reducing CBP
protein using antisense ODNs
Female sexual behavior. Neonatal infusions of CBP antisense
ODNs into the hypothalamus blocked the defeminizing ac-
tions of neonatal testosterone treatment on female sexual
behavior. Androgenized female rats infused neonatally with
CBP antisense ODNs displayed significantly higher levels of
lordosis contrasted with scrambled ODNs infused androg-
enized females (P  0.05, Fig. 6).
Male sexual behavior. In contrast to the effects on female sexual
behavior, neonatal infusions of CBP antisense ODNs into the
hypothalamus did not interfere with the masculinizing ac-
tions of neonatal testosterone treatment on male sexual be-
havior. CBP antisense ODN treatment did not alter the total
number of mounts or mount latencies in androgenized fe-
male rats (P  0.05, Fig. 7).
Effect of CBP antisense ODNs on CBP level. Using Western
immunoblots, we found that neonatal infusions of CBP an-
tisense ODNs into the hypothalamus reduced the expression
of CBP in hypothalamic tissue within 24 h by 30%, contrasted
with scrambled ODN control (P  0.05, Fig. 8).
Discussion
We report here a sex difference in the expression of the
nuclear receptor coactivator, CBP, during neonatal develop-
ment of the rat brain. We found that CBP is present at higher
levels in steroid receptor-containing brain regions of males,
contrasted with females on the day of birth. Males have more
CBP immunoreactive cells within the MPOA, VMH, and Arc,
regions that express high levels of gonadal steroid receptors;
however, there were no sex differences in the number of CBP
immunoreactive cells within the PVP or frontal cortex, re-
gions that express little or no gonadal steroid receptors. To
confirm and extend the immunocytochemical observations,
we used Western immunoblots to determine whether this sex
difference persists throughout the sensitive period for sexual
differentiation of the brain. We found that CBP levels are
higher in the basomedial hypothalamus of males on PN0,
postnatal d 1 and postnatal d 5; however, this sex difference
is gone by postnatal d 11. These findings indicate that CBP
levels are sexually dimorphic within steroid receptor-
containing areas during early postnatal development. Be-
cause most sex differences in the brain are due to steroid
hormone exposure (21, 22), it is likely that steroid hormones
contribute to the sex difference found in CBP levels within
these sexually dimorphic steroid receptor-containing brain
regions.
The sex difference in the levels of CBP within particular
brain regions is likely to impact the activity of multiple ste-
roid receptors. In vitro studies (4, 30) indicate that CBP in-
teracts with receptors for glucocorticoids, estrogens, proges-
tins, thyroid hormone, retinoic acid, and retinoid X as well
as for androgens (31). An important outcome of ligand-
activated steroid receptors is the ability to squelch the ac-
tivity of other steroid receptors. One possible mechanism for
this cross-talk between steroid receptors is by receptors bind-
ing to and limiting the availability of coactivators (4, 6). For
example, ligand-induced transactivation of progestin recep-
tors in HeLa cells can be squelched by estradiol activation of
estrogen receptors, and this phenomenon can be overcome
by increasing the levels of SRC-1 (6). Therefore, it appears
that a limited amount of coactivators is available to bind to
ligand-activated steroid receptors. Our present finding that
CBP is regulated in a sex-specific manner during develop-
ment suggests that the regulation of CBP provides a means
by which one steroid receptor can alter the activity of other
steroid receptors in developing brain. For example, testos-
terone, or its metabolites, may increase the response to other
steroid hormones by increasing the levels of CBP within
particular brain regions.
The immunocytochemical distribution of CBP in neonatal
rat brain closely resembles that observed in adults (16). Al-
FIG. 4. Photomicrograph of Western blot showing increased levels of
CBP within the hypothalamus of males, contrasted to females on the
day of birth. Each lane represents an individual animal. CBP is
recognized as a single protein band at approximately 265 kDa.
FIG. 3. CBP immunoreactive cell number on the day of birth. Mean
number ( SEM) of CBP immunoreactive cells counted bilaterally for
each area from males and females on the day of birth. *, P  0.05.
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though CBP immunoreactivity is widely expressed through-
out the neonatal rat brain, there appears to be some heter-
ogeneity in the levels of CBP as well as sex differences in
these levels. The present immunocytochemical results sug-
gest the sex differences in CBP expression occur only within
sexually dimorphic brain regions that contain steroid recep-
tors, such as the MPOA, VMH, and Arc. It is not known
whether CBP immunoreactivity is found exclusively within
neurons or can be found within glia. The presence of high
levels of CBP may be important to promote cellular re-
sponses to steroids within cell populations that have low
levels of steroid receptors. The distribution of CBP correlates
well with the distribution of the coactivator, SRC-1, in rat
brain (32). Because SRC-1 interacts with CBP at the genome
to enhance steroid receptor-induced transcription, it is not
surprising to find a similar distribution of these coactivators
within the brain. Another parallel between CBP and SRC-1
is the functional role of these coactivators in modulating
steroid-mediated differentiation of sexual behavior.
It is well documented that neonatal testosterone treatment
of females leads to the suppression of adult female sexual
behavior via its aromatization to estradiol (20, 21, 33). Be-
cause CBP is critical for estrogen receptor action in vitro, we
examined whether CBP is required for estrogen receptor
action in developing brain. If CBP is important for estrogen
receptor action, then reducing CBP levels should interfere
with the ability of estradiol to suppress female sexual be-
havior. Therefore, we hypothesized that reducing postnatal
CBP levels in testosterone-treated female rats with antisense
ODNs would block the suppressive actions of estradiol and
lead to increased female sexual behavior. As predicted, tes-
tosterone-treated female rats infused with CBP antisense
ODNs neonatally exhibited higher levels of lordosis as
adults, contrasted with scrambled ODN controls. This indi-
cates that reducing CBP expression interfered with estradi-
ol’s ability to defeminize or reduce female sexual behavior.
Interestingly, reducing CBP expression with antisense ODN
did not interfere with male sexual behavior. There were no
differences between rats treated with CBP antisense ODNs or
control ODN in the number of mounts directed toward an
estrous female, and there were no differences in the latency
to mount an estrous female. Taken together, these data sug-
gest that postnatal expression of CBP may be more important
for processes leading to defeminization than those associated
with masculinization of sexual behavior.
The postnatal disruption of defeminization, but not mas-
culinization, of sexual behavior by reducing CBP expression
is consistent with the effects of reducing SRC-1 expression
neonatally (26). We previously reported that postnatal re-
duction of SRC-1 protein interfered with the defeminizing,
but not the masculinizing, actions of testosterone. These data
are consistent with others (23, 34–37) that report changes in
defeminization, but not masculinization, of sexual behavior.
As stated above, it is well documented that behavioral de-
feminization results from estrogen action (23, 38, 39). How-
ever, behavioral masculinization by testosterone is more
complex, at least in Sprague-Dawley rats (40). Neonatal treat-
ment with an antiandrogen, cyproterone acetate or flut-
FIG. 5. Results of the densitometric analysis of CBP immunoreactive bands shown as a ratio of CBP to the housekeeping gene, GAPDH, within
the hypothalamus of males and females on PN0, postnatal d 1, postnatal d 5, and postnatal d 11. *, P  0.05.
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amide, interferes with behavioral masculinization but has
little impact on behavioral defeminization (40, 41). Further-
more, blocking the aromatization of testosterone to estradiol
neonatally with 1,4,6-androstatriene-3,17-dione disrupts be-
havioral defeminization, but not behavioral masculinization,
of sexual behavior. That is, neonatally 1,4,6-androstatriene-
3,17-dione-treated males exhibit high levels of both male and
female sexual behavior (34). Thus, blocking the conversion of
testosterone into estradiol produces bisexual males that re-
semble those treated neonatally with either SRC-1 or CBP
antisense ODNs. Although our data do not rule out a possible
role for CBP in modulating the development of some com-
ponents of male sexual behavior, they do suggest that co-
activators, such as CBP and SRC-1, may be more important
in processes mediating defeminization than those mediating
masculinization of sexual behavior.
The lack of an effect on masculinization in androgenized
females does not rule out an involvement of CBP in mascu-
linization in males. During development, masculinization of
sexual behavior in males appears to be influenced by two
surges in the synthesis and release of testosterone, one oc-
curring on embryonic d 18 and the other on the day of birth.
Treatment of pregnant rats with an androgen antagonist,
cyproterone acetate, to block androgen action on embryonic
d 18 interferes with masculinization (42). Furthermore, fe-
male rats located near a male within the uterus display in-
creased male sexual behavior in adulthood, and this increase
can be blocked by prenatal treatment with an antiandrogen,
flutamide (43). These studies suggest that a portion of mas-
culinization is due to prenatal testosterone. Therefore, it is
possible that CBP may be involved in mediating some effects
of prenatal testosterone on masculinization.
Another point to consider is that the CBP antisense ODN
reduced protein expression by 30%, as determined by West-
ern immunoblot. This percent reduction is consistent with
FIG. 6. Adult female sexual behavior observed in rats that were neo-
natally treated with testosterone to reduce female sexual behavior.
Reducing CBP with bilateral infusions of antisense ODNs to CBP
mRNA interferes with the suppressive effects of testosterone on fe-
male sexual behavior. Rats infused with CBP antisense ODNs had
higher lordosis quotients and ratings, compared with rats infused
with scrambled control ODNs. *, P  0.05.
FIG. 7. Adult male sexual behavior observed in rats that were neo-
natally treated with testosterone. Reducing CBP with bilateral in-
fusions of antisense ODNs to CBP mRNA did not interfere with the
development of male sexual behavior. Rats infused with CBP anti-
sense ODNs had similar number of mounts and latencies to first
mount, compared with rats infused with scrambled control ODNs.
FIG. 8. CBP antisense ODN infusions decreased the levels of hypo-
thalamic CBP. Histogram represents Western blot analysis of the
densitometric area of CBP immunoreactive bands in rats infused
bilaterally with CBP antisense ODNs or scrambled control ODNs.
The level of CBP is shown as a ratio to GAPDH. *, P  0.05.
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what we observed using SRC-1 antisense ODN, which com-
pletely blocked the defeminizing, but not the masculinizing,
actions of testosterone (26). Typically antisense ODN treat-
ments reduces protein levels by 10–40%, and the behavioral
or physiological effects are more profound (44). It has been
suggested that newly synthesized proteins may be function-
ally preferred over older proteins (44). The Western blot
technique would detect both old and newly synthesized
proteins. Because antisense ODNs interfere preferentially
with the synthesis of new protein, it is possible for antisense
to have a greater impact on physiology than on protein levels.
Although a 30% reduction in CBP attenuated the defemi-
nizing actions of testosterone, a greater reduction of coacti-
vators may be needed to interfere with the masculinization
of sexual behavior. Another possibility is that both CBP and
SRC-1 may need to be reduced to influence masculinization.
Indeed, simultaneous reduction of both CBP and SRC-1 was
required to interfere with adult female sexual behavior and
estradiol induction of progestin receptors (9).
It is important to note that CBP is not only a coactivator for
steroid receptors but is also critically involved in mediating
the actions of CREB (7, 8). When CREB is phosphorylated, it
binds to a cAMP response element located on DNA and then
recruits CBP to the transcriptional complex. Phosphorylation
of CREB occurs following estradiol treatment in both adult
(45–47) and immature neurons (17). Because neonatal males
have higher levels of estradiol, which is aromatized from
testosterone within the brain, it was predicted that males
would have higher levels of CREB phosphorylation. Indeed,
we have recently reported that CREB phosphorylation is
higher in males on the day of birth, contrasted with females
in steroid receptor-containing areas that are sexually dimor-
phic, such as the MPOA, VMH, and the Arc (48). Our present
data indicate that males also express higher levels of CBP
within these same regions. The increased expression of CBP
may act to enhance downstream transcriptional events me-
diated by estradiol-induced phosphorylated CREB. Taken
together, these data suggest that CBP is an important mod-
ulator of estradiol action in developing brain.
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